SCHEMBL357905

SCHEMBL357905

CC(=O)CCC(=O)OCC[N+](C)(C)C

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.83
ADRA1A P35348 1/20 0.83
MAPT P10636 1/20 0.79
BLM P54132 1/20 0.79
CHRM1 P11229 8/20 0.61
CHRM3 P20309 8/20 0.61
CHRM2 P08172 7/20 0.61
CHRM4 P08173 7/20 0.61
CHRM5 P08912 6/20 0.61
CHRNB2 P17787 4/20 0.61
CHRNA4 P43681 4/20 0.61
CHRNA7 P36544 3/20 0.61
HTR1A P08908 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
PGR P06401 1/20 0.61
TBXA2R P21731 1/20 0.61
CHRNB4 P30926 1/20 0.61
CHRNA3 P32297 1/20 0.61
CHRNA10 Q9GZZ6 1/20 0.61
CHRNA9 Q9UGM1 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28824833 0.98 MAPT (0.83) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL41537 0.91 ADRA2A (1.00) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL16320883 0.89 ADRA2A (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL2690356 0.89 ADRA2A (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL21356923 0.89 ADRA2A (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL1643328 0.89 ADRA2A (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL41536 0.89 MAPT (1.00) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL2821312 0.89 ADRA2A (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL1983256 0.86 MAPT (0.95) ADRA2AADRA1AMAPTBLMCHRM1
Suxamethonium SCHEMBL20815392 0.86 MAPT (0.95) ADRA2AADRA1AMAPTBLMCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117069901-A Lignin-based phenolic resin and preparation method thereof 江苏理文造纸有限公司 2023-11-17 CN claimed
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US claimed
CN-105503540-A Method for preparation of benzene ring phenol compound from alkali lignin DALIAN INST CHEMICAL PHYSICS CAS 2016-04-20 CN claimed
CN-105315164-A Environment-friendly choline ionic liquid and preparation method therefor DALIAN CHEMICAL PHYSICS INST 2016-02-10 CN claimed
CN-102449101-A Ionic compounds in lithium bromide/water absorption cycle systems DU PONT 2012-05-09 CN claimed
EP-2414476-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. du Pont de Nemours and Company (US) 2012-02-08 EP claimed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 US claimed
WO-2010117836-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-14 WO claimed
US-20250354930-A1 IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION UNIV MISSISSIPPI (US) 2025-11-20 US disclosed
CN-116549541-B Weight-reducing compound composition and preparation thereof 北京澳特舒尔保健品开发有限公司 2024-04-19 CN disclosed
CN-117069901-A Lignin-based phenolic resin and preparation method thereof 江苏理文造纸有限公司 2023-11-17 CN disclosed
CN-116549541-A Weight-reducing compound composition and preparation thereof 北京澳特舒尔保健品开发有限公司 2023-08-08 CN disclosed
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US disclosed
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION SHINSHU UNIVERSITY (JP) 2017-06-29 US disclosed
CN-105315164-A Environment-friendly choline ionic liquid and preparation method therefor DALIAN CHEMICAL PHYSICS INST 2016-02-10 CN disclosed
CN-105315164-A Environment-friendly choline ionic liquid and preparation method therefor DALIAN CHEMICAL PHYSICS INST 2016-02-10 CN disclosed
CN-102449101-A Ionic compounds in lithium bromide/water absorption cycle systems DU PONT 2012-05-09 CN disclosed
EP-2414476-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. du Pont de Nemours and Company (US) 2012-02-08 EP disclosed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 US disclosed
WO-2010117836-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170182108-A1 FERMENTED FOOD EXTRACT COMPOSITION FIBP, PFKFB2, PFKFB1 ADRA2A 4301/4885ADRA1A 4286/4885MAPT 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.